| MR编号 | NL/H/0137/001 |
|---|
| 药品名称 | Influvac, suspensie voor injectie 0,5 ml |
|---|
| 活性成分 | - A/Darwin/9/2021 (H3N2)-like virus 30.0 µg/ml
- A/Victoria/4897/2022 (H1N1)pdm09-like virus 30.0 µg/ml
- B/Austria/1359417/2021 (B/Victoria lineage)-like virus 30.0 µg/ml
|
|---|
| 剂型 | Suspension for injection |
|---|
| 上市许可持有人 | Abbott Biologicals B.V.
C.J. van Houtenlaan 36
1381 CP Weesp
The Netherlands |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) |
|---|
| 互认成员国 - 产品名称 | - Latvia (LV)
- Portugal (PT)
- Lithuania (LT)
Influvac injekcinė suspensija - Bulgaria (BG)
- Malta (MT)
- Germany (DE)
- Croatia (HR)
- Norway (NO)
- Denmark (DK)
- Cyprus (CY)
Influvac sub-unit® suspension for injection in pre-filled syringe, 15MCG/DOSE - Poland (PL)
Influvac - Belgium (BE)
- Czechia (CZ)
INFLUVAC - Romania (RO)
Influvac suspensie injectabilă în seringa Preumplută - Luxembourg (LU)
- Estonia (EE)
- Slovakia (SK)
- Iceland (IS)
- Finland (FI)
- Slovenia (SI)
- Ireland (IE)
- Greece (GR)
- Sweden (SE)
- Austria (AT)
- Hungary (HU)
Influvac - France (FR)
- Italy (IT)
- Spain (ES)
|
|---|
| 许可日期 | 1998/02/16 |
|---|
| 最近更新日期 | 2025/06/18 |
|---|
| 药物ATC编码 | - J07BB02 influenza, inactivated, split virus or surface antigen
| 申请类型 | - TypeLevel1：[not specified]
- TypeLevel2：[not specified]
- TypeLevel3：[not specified]
- TypeLevel4：[not specified]
- TypeLevel5：[not specified]
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|